Beta-blockers and the treatment of aggression

Harv Rev Psychiatry. 1995 Jan-Feb;2(5):274-81. doi: 10.3109/10673229509017146.

Abstract

This review assesses the usefulness of beta-blockers in the treatment of aggression and describes the parameters for their clinical use. A Medline search using the terms "beta-blockers," "aggression," "propranolol," and "brain injury" identified relevant journal articles published in English between 1977 and 1993. Open, prospective and double-blind, placebo-controlled studies, as well as case reports, were included. Beta-blockers appear to be effective in decreasing the frequency and intensity of aggressive outbursts associated with a wide variety of conditions, such as dementias, attention-deficit disorder, personality disorders, Korsakoff's psychosis, posttraumatic stress disorder, schizophrenia, profound mental retardation, autism, and brain injury. A general discussion attempts to resolve some of the issues surrounding the possible mechanisms of beta-blocker effects, reviews the anatomic and neurochemical bases of aggression, and explores implications of the clinical use of beta-blockers.

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use*
  • Aggression*
  • Antipsychotic Agents / metabolism
  • Antipsychotic Agents / therapeutic use
  • Drug Interactions
  • Humans
  • Mental Disorders / drug therapy*
  • Propranolol / therapeutic use*
  • Psychomotor Agitation / drug therapy
  • Serotonin / metabolism

Substances

  • Adrenergic beta-Antagonists
  • Antipsychotic Agents
  • Serotonin
  • Propranolol